Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 1.345
-3.93 %
$ 196 M
Market Cap
-3.64
P/E
BALANCE SHEET
99.1 M
ASSETS
94.5 M
LIABILITIES
4.58 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Biodesix, Inc.
| Current Assets | 39.7 M |
| Cash & Short-Term Investments | 26.3 M |
| Receivables | 7.68 M |
| Other Current Assets | 5.72 M |
| Non-Current Assets | 59.4 M |
| Long-Term Investments | 0 |
| PP&E | 29.6 M |
| Other Non-Current Assets | 29.8 M |
| Current Liabilities | 33.4 M |
| Accounts Payable | 2.93 M |
| Short-Term Debt | 555 K |
| Other Current Liabilities | 29.9 M |
| Non-Current Liabilities | 61.1 M |
| Long-Term Debt | 60.4 M |
| Other Non-Current Liabilities | 712 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 26.3 | 43.1 | 32.7 | 62.1 | 5.3 | 5.9 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.7 | 5.1 | 3.7 | 15.3 | 5.3 | 1.9 |
| Inventory | 1.4 | 1.4 | 2.9 | 3.2 | 0.8 | 0.7 |
| Other Current Assets | 4.3 | 3.8 | 4.3 | 5.5 | 1.3 | 1.4 |
| Total Current Assets | 39.7 | 53.3 | 43.6 | 86.1 | 12.7 | 9.9 |
| PP&E | 29.6 | 8.8 | 4.2 | 3.2 | 2.1 | 1.4 |
| Intangible Assets | 7.9 | 9.8 | 11.6 | 13.3 | 15.1 | 16.9 |
| Goodwill | 15.0 | 15.0 | 15.0 | 15.0 | 11.6 | 10.8 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 6.9 | 5.9 | 1.7 | 3.5 | 90 K | 99 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 99.1 | 92.9 | 76.1 | 121.1 | 41.6 | 39.1 |
| LIABILITIES | ||||||
| Accounts Payable | 2.9 | 1.7 | 1.7 | 9.0 | 1.7 | 0.9 |
| Short Term Debt | 0.6 | 3.1 | 19 K | 11.8 | 12.2 | 0 |
| Other Current Liabilities | 29.6 | 17.1 | 25.4 | 7.8 | 7.4 | 3.1 |
| Total Current Liabilities | 33.4 | 22.8 | 29.0 | 32.1 | 22.6 | 4.5 |
| Long Term Debt | 60.4 | 30.3 | 10.0 | 15.9 | 23.8 | 23.1 |
| Deferred Tax Income | 0 | (0.4) | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.7 | 19.2 | 17.4 | 31.9 | 223.8 | 209.5 |
| Total Liabilities | 94.5 | 72.3 | 56.4 | 79.9 | 270.2 | 237.1 |
| EQUITY | ||||||
| Common Stock | 96 K | 78 K | 31 K | 27 K | 1 K | 1 K |
| Retained Earnings | (419.6) | (367.4) | (302.0) | (258.8) | (230.9) | (200.1) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | (121.1) | (194.0) | (5.6) |
| Total Equity | 4.6 | 20.6 | 19.7 | 41.2 | (228.5) | (198.0) |
| Total Liabilities and Equity | 99.1 | 92.9 | 76.1 | 121.1 | 41.6 | 39.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 82.1 | 42.1 | 27.4 | 26.6 | 25.5 | 26.5 |